Treatment of diseases like diabetes, cancer, multiple sclerosis or neurodegenerative diseases such as Alzheimer's still poses a tremendous challenge to modern medicine. Nanomedicine, meaning the use of nanotechnology in therapy and diagnostics, may offer promising solutions.
At the EuroNanoMedicine 2009 conference, leading experts from various disciplines such as medicine, nanotechnology, chemistry, cell biology and toxicology will present and discuss recent progress and results. The conference will take place on September 28-30, 2009 in Bled, Slovenia.
The programme will cover current topics such as targeted nanomedicine and therapeutic concepts, overcoming biological barriers, medical diagnostics and sensor devices as well as biocompatibility and toxicity of nanomaterials for medical applications. In addition to scientific issues, political and societal aspects of nanomedicine in Europe will also be adressed.
Nanomaterials are usually known from industrial applications, for example functional surface coatings. In nanomedicine, nanoparticles may be used as drug carriers, protecting the drug against degradation or enhancing uptake by the body. Surface modification of the nano transporters by introducing certain biological functionalities aims at targeted delivery, delivering the drug to the site where it is needed. This can enhance the efficiency of drug intake and decrease potential side effects.
The EuroNanoMedicine 2009 is organized by the multidisciplinary integrated project NanoBioPharmaceutics together with the projects NanoEar and MediTrans. All three projects are funded by the European Commission. Within NanoBioPharmaceutics, 25 partners including 12 university departments, six research institutes, four SMEs and three large pharmaceutical companies from 12 EU countries and the state of Israel are cooperating closely. The project is running for four years and will end in September 2010.
NanoBioPharmaceutics is aiming at the development of biodegradable nanoparticle based carrier systems to transport protein or peptide drugs safely across physiological barriers and release them at the target site within the body. For example, a drug for the treatment of Alzheimer's disease has to pass the blood brain barrier which protects the brain from unwanted or harmful substances. For diabetes patients oral intake of insulin instead of injections would mean a tremendous increase of quality of life. Additionally, NanoBioPharmaceutics investigates new cell culture test systems to compare the results with those obtained from animal testing. A long term goal is to find methods for the reduction and maybe eventually the replacement of animal experiments which are currently required for testing new medication.
At the end of the third project year, a broad range of nanocarrier systems has been designed within NanoBioPharmaceutics. These are currently being optimized and investigated for their suitability to transport drugs via oral or nasal uptake or across the blood brain barrier.Contact:
Munich conference on asteroid detection, tracking and defense
13.06.2018 | Technische Universität München
2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”
08.06.2018 | Helmholtz-Zentrum Geesthacht - Zentrum für Material- und Küstenforschung
Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.
Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...
The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.
Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.
An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.
Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...
Light detection and control lies at the heart of many modern device applications, such as smartphone cameras. Using graphene as a light-sensitive material for...
Water molecules exist in two different forms with almost identical physical properties. For the first time, researchers have succeeded in separating the two forms to show that they can exhibit different chemical reactivities. These results were reported by researchers from the University of Basel and their colleagues in Hamburg in the scientific journal Nature Communications.
From a chemical perspective, water is a molecule in which a single oxygen atom is linked to two hydrogen atoms. It is less well known that water exists in two...
13.06.2018 | Event News
08.06.2018 | Event News
05.06.2018 | Event News
15.06.2018 | Materials Sciences
15.06.2018 | Ecology, The Environment and Conservation
15.06.2018 | Power and Electrical Engineering